Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia 3Recurrence 2Carcinoma, Non-Small-Cell Lung 2Neoplasm Metastasis 1Myeloproliferative Disorders 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Hairy Cell 1Leukemia, Erythroblastic, Acute 1Congenital Abnormalities 1Anemia, Refractory, with Excess of Blasts 1

Interventions

Peripheral Blood Stem Cell Transplantation 24Mycophenolic Acid 16Cyclophosphamide 15fludarabine phosphate 14Tacrolimus 13Rituximab 13Cyclosporine 13Whole-Body Irradiation 12Filgrastim 10Therapeutics 9Radiotherapy 8Psychiatric Rehabilitation 8Flow Cytometry 8Etoposide 8Methylprednisolone 7Methotrexate 7Busulfan 7Antilymphocyte Serum 7Polymerase Chain Reaction 6obinutuzumab 4Vemurafenib 4Ondansetron 4Melphalan 4Granulocyte Colony-Stimulating Factor 4Cord Blood Stem Cell Transplantation 4Cladribine 4Bortezomib 4Transplantation 3Sirolimus 3Lenalidomide 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Leukemia, Hairy Cell × Biological Therapy × Clear all
NCT00462189 2007-04-18

Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance Disease

Cambridge Antibody Technology

Phase 1 Unknown
40 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡